{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:04Z","timestamp":1772165764117,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13162-0","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T18:36:56Z","timestamp":1731523016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of single-dose prophylactic methotrexate in the prevention of post-molar gestational trophoblastic neoplasia in patients with high-risk molar pregnancy"],"prefix":"10.1186","volume":"24","author":[{"given":"Setareh","family":"Akhavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloufar","family":"Hoorshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam sadat","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrzad","family":"Sheikhhasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elahe","family":"Rezayof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"issue":"1","key":"13162_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ygyno.2017.10.028","volume":"148","author":"I Maest\u00e1","year":"2018","unstructured":"Maest\u00e1 I, et al. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: the New England Trophoblastic Disease Center experience. Gynecol Oncol. 2018;148(1):161\u20137.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"13162_CR2","first-page":"692","volume":"45","author":"JO Schorge","year":"2000","unstructured":"Schorge JO, et al. Recent advances in gestational trophoblastic disease. J Reprod Med. 2000;45(9):692\u2013700.","journal-title":"J Reprod Med"},{"issue":"2","key":"13162_CR3","first-page":"183","volume":"82","author":"E Yamamoto","year":"2020","unstructured":"Yamamoto E, et al. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study. Nagoya J Med Sci. 2020;82(2):183.","journal-title":"Nagoya J Med Sci"},{"key":"13162_CR4","doi-asserted-by":"crossref","unstructured":"Lurain J, Seckl M, Schink J. Gestational trophoblastic disease. Textbook Uncommon Cancer, 2017: pp. 653\u201362.","DOI":"10.1002\/9781119196235.ch45"},{"issue":"11","key":"13162_CR5","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.6004\/jnccn.2019.0053","volume":"17","author":"NR Abu-Rustum","year":"2019","unstructured":"Abu-Rustum NR, et al. Gestational trophoblastic neoplasia, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(11):1374\u201391.","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"13162_CR6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ygyno.2008.09.005","volume":"112","author":"RS Berkowitz","year":"2009","unstructured":"Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gynecol Oncol. 2009;112(3):654\u201362.","journal-title":"Gynecol Oncol"},{"key":"13162_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ijgo.13877","volume":"155","author":"HYS Ngan","year":"2021","unstructured":"Ngan HYS, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynecol Obstet. 2021;155:86\u201393.","journal-title":"Int J Gynecol Obstet"},{"issue":"5","key":"13162_CR8","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/0002-9378(66)90423-6","volume":"96","author":"J Lewis Jr","year":"1966","unstructured":"Lewis J Jr, et al. Treatment of trophoblastic disease: with rationale for the use of adjunctive chemotherapy at the time of indicated operation. Am J Obstet Gynecol. 1966;96(5):710\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"13162_CR9","doi-asserted-by":"crossref","unstructured":"Wang Q et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Reviews, 2017(9).","DOI":"10.1002\/14651858.CD007289.pub3"},{"key":"13162_CR10","unstructured":"Hancock BW. Differences in management and treatment: a critical appraisal. Gestational trophoblastic disease, 1997: pp. 213\u2013216."},{"issue":"Suppl 2","key":"13162_CR11","first-page":"S130","volume":"119","author":"HY Ngan","year":"2012","unstructured":"Ngan HY, et al. Trophoblastic disease. Int J Gynaecol Obstet. 2012;119(Suppl 2):S130\u20136.","journal-title":"Int J Gynaecol Obstet"},{"issue":"11","key":"13162_CR12","first-page":"1420","volume":"121","author":"M Seckl","year":"2014","unstructured":"Seckl M. Time to stop offering prophylactic chemotherapy after molar pregnancies? BJOG: Int J Obstet Gynecol. 2014;121(11):1420.","journal-title":"BJOG: Int J Obstet Gynecol"},{"key":"13162_CR13","doi-asserted-by":"crossref","unstructured":"Mangili G et al. Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup. Int J Gynecologic Cancer, 2014. 24(Supp 3).","DOI":"10.1097\/IGC.0000000000000294"},{"issue":"7\u20138","key":"13162_CR14","first-page":"305","volume":"55","author":"PD Soares","year":"2010","unstructured":"Soares PD, et al. Geographical distribution and demographic characteristics of gestational trophoblastic disease. J Reprod Med. 2010;55(7\u20138):305\u201310.","journal-title":"J Reprod Med"},{"key":"13162_CR15","doi-asserted-by":"crossref","unstructured":"Wolfberg AJ, et al. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Volume 107. Obstetrics & Gynecology; 2006; 743. 3.","DOI":"10.1097\/01.AOG.0000203431.95377.76"},{"key":"13162_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0020-7292(03)90120-2","volume":"83","author":"HYS Ngan","year":"2003","unstructured":"Ngan HYS, et al. Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynecol Obstet. 2003;83:175\u20137.","journal-title":"Int J Gynecol Obstet"},{"key":"13162_CR17","doi-asserted-by":"crossref","unstructured":"Kim DS, et al. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Volume 67. Obstetrics & Gynecology; 1986. pp. 690\u20134. 5.","DOI":"10.1097\/00006250-198605000-00017"},{"issue":"3","key":"13162_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/1097-0142(19860801)58:3<624::AID-CNCR2820580305>3.0.CO;2-6","volume":"58","author":"Y Kashimura","year":"1986","unstructured":"Kashimura Y, et al. Prophylactic chemotherapy for hydatidiform mole five to 15 years follow-up. Cancer. 1986;58(3):624\u20139.","journal-title":"Cancer"},{"issue":"2","key":"13162_CR19","first-page":"110","volume":"46","author":"S Limpongsanurak","year":"2001","unstructured":"Limpongsanurak S. Prophylactic actinomycin D for high-risk complete hydatidiform mole. J Reprod Med. 2001;46(2):110\u20136.","journal-title":"J Reprod Med"},{"issue":"6","key":"13162_CR20","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.31557\/APJCP.2020.21.6.1755","volume":"21","author":"S Aminimoghaddam","year":"2020","unstructured":"Aminimoghaddam S, Mahmoudzadeh F, Mohammadi M. Prophylactic chemotherapy with methotrexate leucovorin in high-risk hydatidiform mole. Asian Pac J Cancer Prevention: APJCP. 2020;21(6):1755.","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"issue":"1","key":"13162_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-022-02134-w","volume":"23","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia. BMC Womens Health. 2023;23(1):1\u20138.","journal-title":"BMC Womens Health"},{"issue":"1","key":"13162_CR22","first-page":"24","volume":"46","author":"S Geng","year":"2011","unstructured":"Geng S, et al. Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole. Zhonghua Fu Chan Ke Za Zhi. 2011;46(1):24\u20137.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"3","key":"13162_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ygyno.2009.09.012","volume":"115","author":"EMH Uberti","year":"2009","unstructured":"Uberti EMH, et al. Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy. Gynecol Oncol. 2009;115(3):476\u201381.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13162-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13162-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13162-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T19:06:06Z","timestamp":1731524766000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13162-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["13162"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13162-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3630013\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"18 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was carried out in compliance with the Helsinki Declaration and was approved by the ethical committee at Tehran University of Medical Sciences IR.TUMS.IKHC.REC.1399.261. Informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1400"}}